These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36694460)

  • 1. Understanding Ohio X-Waivered Advanced Practice Registered Nurses' Rate of Naltrexone Prescription for Alcohol Use Disordered Patients.
    Wiggins M; Painter S; Burant C; Juratovac E; Alto K
    J Am Psychiatr Nurses Assoc; 2024; 30(3):613-623. PubMed ID: 36694460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomy and empowerment in advanced practice registered nurses: lessons from New Mexico.
    Petersen PA; Keller T; Way SM; Borges WJ
    J Am Assoc Nurse Pract; 2015 Jul; 27(7):363-70. PubMed ID: 25581473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRNs' controlled substance prescribing and readiness following Florida legislative changes.
    Reynolds AM; Reynolds CJ; Craig-Rodriguez A
    Nurse Pract; 2021 Jun; 46(6):48-55. PubMed ID: 34004642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and analysis of a multifaceted intervention for alcohol use disorder from a single academic urban emergency department.
    Duvalyan E; Falade I; Fan W; Foe M; Mvemba A; Zussman JW; Geier C; LeSaint KT; Graglia S
    Acad Emerg Med; 2024 May; 31(5):456-462. PubMed ID: 38380769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of the Achieving Effective & Safe Opioid Prescribing-Advanced Practice Registered Nurse (AESOP-APRN) Survey: A Pilot Study.
    Bruckenthal P; Gilson AM
    Pain Manag Nurs; 2019 Jun; 20(3):214-221.e3. PubMed ID: 31101559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State variation in opioid and benzodiazepine prescriptions between independent and nonindependent advanced practice registered nurse prescribing states.
    Schirle L; McCabe BE
    Nurs Outlook; 2016; 64(1):86-93. PubMed ID: 26712387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Education Intervention to Increase Naltrexone Use Among Adult Inpatients With Alcohol Use Disorder.
    Ipsarides J
    J Psychosoc Nurs Ment Health Serv; 2023 Sep; 61(9):10-14. PubMed ID: 37134282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research to practice: adoption of naltrexone in alcoholism treatment.
    Thomas CP; Wallack SS; Lee S; McCarty D; Swift R
    J Subst Abuse Treat; 2003 Jan; 24(1):1-11. PubMed ID: 12646325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding access to nurse-managed medication for opioid use disorder.
    Cos TA; Starbird LE; Lee H; Chun B; Gonnella K; Bird J; Livsey K; Bastos S; O'Brien M; Clark I; Jenkins D; Tavolaro-Ryley L
    Nurs Outlook; 2021; 69(5):848-855. PubMed ID: 33992445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
    Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
    JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
    Muvvala SB; O'Malley SS; Rosenheck R
    Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Providing a complete episode of care": A survey of registered nurse and registered midwife prescribing behaviours and practices.
    Casey M; Rohde D; Higgins A; Buckley T; Cashin A; Fong J; Hughes M; McHugh A
    J Clin Nurs; 2020 Jan; 29(1-2):152-162. PubMed ID: 31610060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.
    Korthuis PT; Lum PJ; Vergara-Rodriguez P; Ahamad K; Wood E; Kunkel LE; Oden NL; Lindblad R; Sorensen JL; Arenas V; Ha D; Mandler RN; McCarty D;
    Addiction; 2017 Jun; 112(6):1036-1044. PubMed ID: 28061017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.
    Iheanacho T; Issa M; Marienfeld C; Rosenheck R
    Drug Alcohol Depend; 2013 Sep; 132(1-2):122-6. PubMed ID: 23434041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization.
    Kranzler HR; Stephenson JJ; Montejano L; Wang S; Gastfriend DR
    Addiction; 2008 Nov; 103(11):1801-8. PubMed ID: 19032530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
    Abraham AJ; Knudsen HK; Roman PM
    J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.